EMERGING DIGITAL TECHNOLOGIES IN MONITORING ENDOCRINE DISORDERS: CONTINUOUS GLUCOSE MONITORING SYSTEMS AND ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME
DOI:
https://doi.org/10.31435/ijitss.1(49).2026.4658Keywords:
Endocrine Disorders, Diabetes, Polycystic Ovary Syndrome (PCOS), Continuous Glucose Monitoring (CGM), Artificial Intelligence (AI), Metabolic HealthAbstract
Introduction and objective: Endocrine disorders affect the regulation of metabolic processes and are often associated with disturbances in glucose and hormonal homeostasis.
In recent years, digital tools have increasingly contributed to the diagnosis and monitoring of metabolic diseases. Technological advancements have introduced continuous glucose monitoring (CGM) for patients with diabetes, as well as artificial intelligence (AI) algorithms to support the assessment of hormonal and imaging parameters in the diagnosis of PCOS. Despite these advances, studies on patients with diabetes using CGM who are simultaneously diagnosed with PCOS remain limited. AI-based diagnostic tools show promising accuracy in detecting PCOS characteristics through hormonal profiles and ultrasound imaging.
The aim of this review is to summarize current evidence on CGM systems and AI in the evaluation and diagnosis of endocrine disorders, focusing on diabetes and PCOS.
Methods: This narrative review analyzed literature from 2019–2025 and one earlier publication using PubMed and Google Scholar, focusing on CGM, AI, and diagnostic approaches in endocrine disorders.
Results: CGM provides valuable insight into glucose variability and metabolic patterns in diabetes, but evidence for its use in patients with concurrent PCOS is limited. AI-based tools demonstrate high accuracy in identifying PCOS features, especially through hormonal profiling and ultrasound analysis.
Conclusion: Digital technologies such as CGM and AI offer promising opportunities to improve the evaluation and management of endocrine disorders, particularly in women with PCOS. Larger, standardized studies are needed to validate clinical utility and support integration into routine care.
References
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020). Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Molecular Metabolism, 35(100937), 100937. https://doi.org/10.1016/j.molmet.2020.01.001
Dong, J., & Rees, D. A. (2023). Polycystic ovary syndrome: pathophysiology and therapeutic opportunities. BMJ Medicine, 2(1), e000548. https://doi.org/10.1136/bmjmed-2023-000548
Salari, N., Nankali, A., Ghanbari, A., Jafarpour, S., Ghasemi, H., Dokaneheifard, S., & Mohammadi, M. (2024). Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis. Archives of Gynecology and Obstetrics, 310(3), 1303–1314. https://doi.org/10.1007/s00404-024-07607-x
Wu, H., Patterson, C. C., Zhang, X., Ghani, R. B. A., Magliano, D. J., Boyko, E. J., Ogle, G. D., & Luk, A. O. Y. (2022). Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021. Diabetes Research and Clinical Practice, 185(109785), 109785. https://doi.org/10.1016/j.diabres.2022.109785
IDF Diabetes Atlas. (2024, July 18). Diabetes Atlas. https://diabetesatlas.org/
Pyper, E., McKeown, S., Hartmann-Boyce, J., & Powell, J. (2023). Digital health technology for real-world clinical outcome measurement using patient-generated data: Systematic scoping review. Journal of Medical Internet Research, 25, e46992. https://doi.org/10.2196/46992
Abdulazeem, H. M., Meckawy, R., Schwarz, S., Novillo-Ortiz, D., & Klug, S. J. (2025). Knowledge, attitude, and practice of primary care physicians toward clinical AI-assisted digital health technologies: Systematic review and meta-analysis. International Journal of Medical Informatics, 201(105945), 105945.https://doi.org/10.1016/j.ijmedinf.2025.105945
Zhang, K., Qi, Y., Wang, W., Tian, X., Wang, J., Xu, L., & Zhai, X. (2025). Future horizons in diabetes: integrating AI and personalized care. Frontiers in Endocrinology, 16, 1583227. https://doi.org/10.3389/fendo.2025.1583227
Kwon, S. Y., & Moon, J. S. (2025). Advances in continuous glucose monitoring: Clinical applications. Endocrinology and Metabolism, 40(2), 161–173. https://doi.org/10.3803/EnM.2025.2370
Wu, X., Zhao, X., Chen, W., Chen, Q., Kong, L., & Li, P. (2025). A systematic review of continuous glucose monitoring sensors: principles, core technologies and performance evaluation. Sensors and ActuatorsReports, 10(100361), 100361. https://doi.org/10.1016/j.snr.2025.100361
Rizzi, A., Polimeno, T., Leo, M. L., Moriconi, A., Policriti, M., Tartaglione, L., Merola, A., Tropea, A., Apa, R., &Pitocco, D. (2025). Different glucose variability in women with polycystic ovary syndrome with and without insulin resistance: A pilot study. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 31(11), 1407–1413. https://doi.org/10.1016/j.eprac.2025.06.020
Hu, S., Song, D., Wan, S., Zhang, S., Luo, C., Li, N., Liu, G., da Graça Espírito Santo Vasconcelos, J., de Carvalho, L. L. C., Neobísi, E., da Costa, M. L. B., EtchuTakounjou, J., Neves, K. M. D., Dos Ramos da Conceição, L., da Costa Encarnação, M., & Zhao, L.-Y. (2025). Digital health: current applications, challenges, and future directions for enhancing healthcare quality and safety. Frontiers in Public Health, 13(1646802), 1646802. https://doi.org/10.3389/fpubh.2025.1646802
Giorgini, F., Di Dalmazi, G., &Diciotti, S. (2024). Artificial intelligence in endocrinology: a comprehensive review. Journal of EndocrinologicalInvestigation, 47(5), 1067–1082. https://doi.org/10.1007/s40618-023-02235-9
Maida, E., Caruso, P., Bonavita, S., Abbadessa, G., Miele, G., Longo, M., Scappaticcio, L., Ruocco, E., Trojsi, F., Esposito, K., Lavorgna, L., &Maiorino, M. I. (2025). Digital health in diabetes care: A narrative review from monitoring to the management of systemic and neurologic complications. Journal of ClinicalMedicine, 14(12), 4240. https://doi.org/10.3390/jcm14124240
Krall, J. S., Childs, B., & Mehrotra, N. (2023). Mobile applications to support diabetes self-management education: Patient experiences and provider perspectives. Journal of Diabetes Science and Technology, 17(5), 1206–1211. https://doi.org/10.1177/19322968231174037
Sharma, V., Feldman, M., & Sharma, R. (2024). Telehealth technologies in diabetes self-management and education. Journal of Diabetes Science and Technology, 18(1), 148–158. https://doi.org/10.1177/19322968221093078
Wright, P. J., Burts, C., Harmon, C., & Corbett, C. F. (2025). Availability and use of digital technology among women with polycystic ovary syndrome: Scoping review. JMIR Infodemiology, 5, e68469.https://doi.org/10.2196/68469
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023). The crucial role and mechanism of insulin resistance in metabolic disease. Frontiers in Endocrinology, 14, 1149239. https://doi.org/10.3389/fendo.2023.1149239
Wang, J., Chen, R., Long, H., He, J., Tang, M., Su, M., Deng, R., Chen, Y., Ni, R., Zhao, S., Rao, M., Wang, H., & Tang, L. (2025). Artificial intelligence in polycystic ovarian syndrome management: past, present, and future. La Radiologia Medica, 130(9), 1409–1441. https://doi.org/10.1007/s11547-025-02032-9
Duffy, A., Christie, G. J., & Moreno, S. (2022). The challenges toward real-world implementation of digital health design approaches: Narrative review. JMIR Human Factors, 9(3), e35693. https://doi.org/10.2196/35693
Bidlingmaier, M., Gleeson, H., Latronico, A.-C., & Savage, M. O. (2022). Applying precision medicine to the diagnosis and management of endocrine disorders. EndocrineConnections, 11(10). https://doi.org/10.1530/EC-22-0177
Mian, Z., Hermayer, K. L., & Jenkins, A. (2019). Continuous glucose monitoring: Review of an innovation in diabetes management. The American Journal of the Medical Sciences, 358(5), 332–339. https://doi.org/10.1016/j.amjms.2019.07.003
Rodbard, D. (2016). Continuous glucose monitoring: A review of successes, challenges, and opportunities. Diabetes Technology & Therapeutics, 18 Suppl 2(S2), S3–S13. https://doi.org/10.1089/dia.2015.0417
Link, M., Kamecke, U., Waldenmaier, D., Pleus, S., Garcia, A., Haug, C., &Freckmann, G. (2021). Comparative accuracy analysis of a real-time and an intermittent-scanning continuous glucose monitoring system. Journal of Diabetes Science and Technology, 15(2), 287–293. https://doi.org/10.1177/1932296819895022
Kim, J. Y., Kim, S., & Kim, J. H. (2025). Comparison of real-time and intermittently-scanned continuous glucose monitoring for glycemic control in type 1 diabetes mellitus: Nationwide cohort study. Diabetes&MetabolismJournal, 49(3), 436–447. https://doi.org/10.4093/dmj.2024.0160
Zhou, Y., Sardana, D., Kuroko, S., Haszard, J. J., de Block, M. I., Weng, J., Jefferies, C., & Wheeler, B. J. (2024). Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials. Diabetic Medicine: A Journal of the British Diabetic Association, 41(3), e15280. https://doi.org/10.1111/dme.15280
Klonoff, D. C., Nguyen, K. T., Xu, N. Y., Gutierrez, A., Espinoza, J. C., & Vidmar, A. P. (2023). Use of continuous glucose monitors by people without diabetes: An idea whose time has come? Journal of Diabetes Science and Technology, 17(6), 1686–1697. https://doi.org/10.1177/19322968221110830
DehghaniZahedani, A., ShariatTorbaghan, S., Rahili, S., Karlin, K., Scilley, D., Thakkar, R., Saberi, M., Hashemi, N., Perelman, D., Aghaeepour, N., McLaughlin, T., & Snyder, M. P. (2021). Improvement in glucose regulation using a digital tracker and continuous glucose monitoring in healthy adults and those with type 2 diabetes. Diabetes Therapy: Research, Treatment and Education of Diabetes and Related Disorders, 12(7), 1871–1886. https://doi.org/10.1007/s13300-021-01081-3
Rädel, C., Wienke, A., &Pliquett, R. U. (2025). Continuous glucose monitoring in non-insulin-dependent type-2 diabetes - rationale for CGM-NIDDM study. Diabetology&MetabolicSyndrome, 17(1), 397. https://doi.org/10.1186/s13098-025-01976-2
Zahalka, S. J., Galindo, R. J., Shah, V. N., & Low Wang, C. C. (2024). Continuous glucose monitoring for prediabetes: What are the best metrics? Journal of Diabetes Science and Technology, 18(4), 835–846. https://doi.org/10.1177/19322968241242487
Basu, A., Dube, S., Slama, M., Errazuriz, I., Amezcua, J. C., Kudva, Y. C., Peyser, T., Carter, R. E., Cobelli, C., & Basu, R. (2013). Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes, 62(12), 4083–4087. https://doi.org/10.2337/db13-1132
Kuroda, A., Taniguchi, S., Akehi, Y., Mori, H., Tamaki, M., Suzuki, R., Otsuka, Y., &Matsuhisa, M. (2017). Accuracy and time delay of glucose measurements of continuous glucose monitoring and bedside artificial pancreas during hyperglycemic and euglycemic hyperinsulinemic glucose clamp study. Journal of Diabetes Science and Technology, 11(6), 1096–1100. https://doi.org/10.1177/1932296817735122
Pandit, K. (2012). Continuous glucose monitoring. Indian Journal of Endocrinology and Metabolism, 16(Suppl 2), S263-6. https://doi.org/10.4103/2230-8210.104056
Core glycemic metrics explained. TIR, TBR, TAR, GMI, CV, and mean glucose for diabetes care. (n.d.). ADCES. Retrieved December 1, 2025, from https://www.adces.org/education/danatech/glucose-monitoring/continuous-glucose-monitors-(cgm)/glycemic-metrics--an-overview?utm_source
Dmitrovic, R., Katcher, H. I., Kunselman, A. R., &Legro, R. S. (2011). Continuous glucose monitoring during pregnancy in women with polycystic ovary syndrome. Obstetrics and Gynecology, 118(4), 878–885. https://doi.org/10.1097/AOG.0b013e31822c887f
Tauschmann, M., Cardona-Hernandez, R., DeSalvo, D. J., Hood, K., Laptev, D. N., Lindholm Olinder, A., Wheeler, B. J., & Smart, C. E. (2024). International Society for Pediatric and Adolescent Diabetes clinical practice consensus guidelines 2024 diabetes technologies: Glucose monitoring. HormoneResearch in Paediatrics, 97(6), 615–635. https://doi.org/10.1159/000543156
Fokkert, M. J., van Dijk, P. R., Edens, M. A., Abbes, S., de Jong, D., Slingerland, R. J., & Bilo, H. J. G. (2017). Performance of the FreeStyle Libre Flash glucose monitoring system in patients with type 1 and 2 diabetes mellitus. BMJ Open Diabetes Research & Care, 5(1), e000320. https://doi.org/10.1136/bmjdrc-2016-000320
Gu, J., Zhao, Z., Li, H., Li, B., Chen, S., Cao, Y., Li, N., & Lu, X. (2025). Accuracy of Freestyle Libre continuous glucose monitoring system in critically ill patients after cardiac surgery. Journal of CardiothoracicSurgery, 20(1), 75. https://doi.org/10.1186/s13019-024-03229-1
Wen, X., Zeng, N., Zhang, N., Ou, T., Li, X., Li, X., Li, W., Xu, K., & Du, T. (2022). Diabetes complications and related comorbidities impair the accuracy of FreeStyle libre, a flash continuous glucose monitoring system, in patients with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 15, 3437–3445. https://doi.org/10.2147/DMSO.S381565
Richardson, K. M., Jospe, M. R., Bohlen, L. C., Crawshaw, J., Saleh, A. A., &Schembre, S. M. (2024). The efficacy of using continuous glucose monitoring as a behaviour change tool in populations with and without diabetes: a systematic review and meta-analysis of randomised controlled trials. The International Journal of Behavioral Nutrition and Physical Activity, 21(1), 145. https://doi.org/10.1186/s12966-024-01692-6
Ma, Y., Deng, S., Xie, W., Weng, M., &Jia, Y. (2025). Effectiveness of an individualized diabetes health education program using real-time continuous glucose monitoring in improving blood glucose: A pilot interventional study on subjects with prediabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 18, 1939–1948. https://doi.org/10.2147/DMSO.S511187
Jospe, M. R., Richardson, K. M., Saleh, A. A., Bohlen, L. C., Crawshaw, J., Liao, Y., Konnyu, K., &Schembre, S. M. (2024). Leveraging continuous glucose monitoring as a catalyst for behaviour change: a scoping review. The International Journal of Behavioral Nutrition and Physical Activity, 21(1), 74. https://doi.org/10.1186/s12966-024-01622-6
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., &Piltonen, T. T. (2024). Polycystic ovary syndrome. Nature reviews. Disease primers, 10(1), 27. https://doi.org/10.1038/s41572-024-00511-3
Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., Norman, R. J., Mousa, A., Joham, A. E., & International PCOS Network (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. European Journal of Endocrinology, 189(2), G43–G64. https://doi.org/10.1093/ejendo/lvad096
Moral, P., Mustafi, D., Mustafi, A., & Sahana, S. K. (2024). CystNet: An AI driven model for PCOS detection using multilevel thresholding of ultrasound images. Scientific Reports, 14(1), 25012. https://doi.org/10.1038/s41598-024-75964-3
Suha, S. A., & Islam, M. N. (2022). An extended machine learning technique for polycystic ovary syndrome detection using ovary ultrasound image. Scientific Reports, 12(1), 17123.https://doi.org/10.1038/s41598-022-21724-0
Bharati, S., Podder, P., & Hossain Mondal, M. R. (2020). Diagnosis of Polycystic Ovary Syndrome Using Machine Learning Algorithms. In 2020 IEEE Region 10 Symposium (TENSYMP) (pp. 1486–1489). 2020 IEEE Region 10 Symposium (TENSYMP). IEEE. https://doi.org/10.1109/tensymp50017.2020.9230932
Elmannai, H., El-Rashidy, N., Mashal, I., Alohali, M. A., Farag, S., El-Sappagh, S., & Saleh, H. (2023). Polycystic Ovary Syndrome Detection Machine Learning Model Based on Optimized Feature Selection and Explainable Artificial Intelligence. Diagnostics, 13(8), 1506. https://doi.org/10.3390/diagnostics13081506
Agirsoy, M., &Oehlschlaeger, M. A. (2025). A machine learning approach for non-invasive PCOS diagnosis from ultrasound and clinical features. Scientific Reports, 15(1), 33638.https://doi.org/10.1038/s41598-025-10453-9
Alamoudi, A., Khan, I. U., Aslam, N., Alqahtani, N., Alsaif, H. S., Al Dandan, O., Al Gadeeb, M., & Al Bahrani, R. (2023). A Deep Learning Fusion Approach to Diagnosis the Polycystic Ovary Syndrome (PCOS). Applied Computational Intelligence and Soft Computing, 2023, 1–15. https://doi.org/10.1155/2023/9686697
Wang, W., Zeng, W., He, S., Shi, Y., Chen, X., Tu, L., Yang, B., Xu, J., & Yin, X. (2023). A new model for predicting the occurrence of polycystic ovary syndrome: Based on data of tongue and pulse. Digital Health, 9. https://doi.org/10.1177/20552076231160323
Giorgini, F., Di Dalmazi, G., &Diciotti, S. (2023). Artificial intelligence in endocrinology: a comprehensive review. Journal of Endocrinological Investigation, 47(5), 1067–1082. https://doi.org/10.1007/s40618-023-02235-9
Wang, J., Chen, R., Long, H., He, J., Tang, M., Su, M., Deng, R., Chen, Y., Ni, R., Zhao, S., Rao, M., Wang, H., & Tang, L. (2025). Artificial intelligence in polycystic ovarian syndrome management: past, present, and future. La Radiologia Medica, 130(9), 1409–1441. https://doi.org/10.1007/s11547-025-02032-9
khan, B., Fatima, H., Qureshi, A., Kumar, S., Hanan, A., Hussain, J., & Abdullah, S. (2023). Drawbacks of Artificial Intelligence and Their Potential Solutions in the Healthcare Sector. Biomedical Materials & Devices, 1(2), 731–738. https://doi.org/10.1007/s44174-023-00063-2
Verma, P., Maan, P., Gautam, R., &Arora, T. (2024). Unveiling the Role of Artificial Intelligence (AI) in Polycystic Ovary Syndrome (PCOS) Diagnosis: A Comprehensive Review. Reproductive Sciences, 31(10), 2901–2915. https://doi.org/10.1007/s43032-024-01615-7
Wang, J., Wu, D., Guo, H., & Li, M. (2019). Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sciences, 236, 116940. https://doi.org/10.1016/j.lfs.2019.116940
Aggarwal, S., & Pandey, K. (2023). Early identification of PCOS with commonly known diseases: Obesity, diabetes, high blood pressure and heart disease using machine learning techniques. Expert Systems with Applications, 217, 119532. https://doi.org/10.1016/j.eswa.2023.119532
van Doorn, W. P. T. M., Foreman, Y. D., Schaper, N. C., Savelberg, H. H. C. M., Koster, A., van der Kallen, C. J. H., Wesselius, A., Schram, M. T., Henry, R. M. A., Dagnelie, P. C., de Galan, B. E., Bekers, O., Stehouwer, C. D. A., Meex, S. J. R., & Brouwers, M. C. G. J. (2021). Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study. PloS One, 16(6), e0253125. https://doi.org/10.1371/journal.pone.0253125
Ji, C., Jiang, T., Liu, L., Zhang, J., & You, L. (2025). Continuous glucose monitoring combined with artificial intelligence: redefining the pathway for prediabetes management. Frontiers in Endocrinology, 16. https://doi.org/10.3389/fendo.2025.1571362
Shamanna, P., Erukulapati, R. S., Shukla, A., Shah, L., Willis, B., Thajudeen, M., Kovil, R., Baxi, R., Wali, M., Damodharan, S., & Joshi, S. (2024). One-year outcomes of a digital twin intervention for type 2 diabetes: a retrospective real-world study. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-76584-7
Shamanna, P., Maheshwari, A., Keshavamurthy, A., Bhat, S., Kulkarni, A., R, S., K, K., Gupta, M., Thajudeen, M., Kulkarni, R., Patil, S., & Joshi, S. (2025). Digital Twin Technology in Resolving Polycystic Ovary Syndrome and Improving Metabolic Health: A Comprehensive Case Study. AACE Clinical Case Reports, 11(1), 70–74. https://doi.org/10.1016/j.aace.2024.11.004
Zhang, S., He, H., Wang, Y., Wang, X., & Liu, X. (2023). Transcutaneous auricular vagus nerve stimulation as a potential novel treatment for polycystic ovary syndrome. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-34746-z
Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., &Arora, T. (2025). The Role of Lifestyle Interventions in PCOS Management: A Systematic Review. Nutrients, 17(2), 310. https://doi.org/10.3390/nu17020310
Kalra, B., Kapoor, N., Dhingra, A., &Kalra, S. (2024). The International Evidence-based Guidelines for the Assessment and Management of Polycystic Ovary Syndrome: An Exemplar of Person-centred Care. touchREVIEWS in Endocrinology, 20(2). https://doi.org/10.17925/ee.2024.20.2.1
Birnbaum, F., Lewis, D., Rosen, R. K., & Ranney, M. L. (2015). Patient Engagement and the Design of Digital Health. Academic Emergency Medicine, 22(6), 754–756. https://doi.org/10.1111/acem.12692
Shanmugavadivel, K., M S, M. D., T R, M., Al-Shehari, T., Alsadhan, N. A., &Yimer, T. E. (2024). Optimized polycystic ovarian disease prognosis and classification using AI based computational approaches on multi-modality data. BMC Medical Informatics and Decision Making, 24(1). https://doi.org/10.1186/s12911-024-02688-9
Chaturvedi, U., Chauhan, S. B., & Singh, I. (2025). The impact of artificial intelligence on remote healthcare: Enhancing patient engagement, connectivity, and overcoming challenges. Intelligent Pharmacy, 3(5), 323–329. https://doi.org/10.1016/j.ipha.2024.12.003
Barrera, F. J., Brown, E. D. L., Rojo, A., Obeso, J., Plata, H., Lincango, E. P., Terry, N., Rodríguez-Gutiérrez, R., Hall, J. E., & Shekhar, S. (2023). Application of machine learning and artificial intelligence in the diagnosis and classification of polycystic ovarian syndrome: a systematic review. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1106625
Downloads
Published
Issue
Section
License
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
